| BID | 77.81 | ASK | 79.34 | ||
| Open | 78.37 | Previous Close | 78.37 | ||
| Pre-Market | - | After-Market | 78.25 | ||
| - - | - -% |
| Target Price | 78.64 | Analyst Rating | Moderate Buy 1.69 | |
| Potential % | 0.50 | Finscreener Ranking | ★+ 43.88 | |
| Insiders Trans % 3/6/12 mo. | -/-/- | Value Ranking | ★★ 46.28 | |
| Insiders Value % 3/6/12 mo. | -/-/- | Growth Ranking | ★★+ 47.27 | |
| Insiders Shares Cnt. % 3/6/12 mo. | -/-/- | Income Ranking | ★ 31.86 | |
| Price Range Ratio 52W % | 74.35 | Earnings Rating | — | |
| Market Cap | 39.10B | Earnings Date | 15th Aug 2023 | |
| Alpha | 0.00 | Standard Deviation | 0.08 | |
| Beta | 0.89 |
Today's Price Range 78.1778.79 | 52W Range 55.2186.20 |
Summary:
Sell
| Technical Indicators: | Sell |
| Moving Averages: | Strong Sell |
| Performance | |||
|---|---|---|---|
| 1 Week | -4.49% | ||
| 1 Month | -7.33% | ||
| 3 Months | -2.80% | ||
| 6 Months | 16.97% | ||
| 1 Year | 26.85% | ||
| 3 Years | 38.37% | ||
| 5 Years | - | ||
| 10 Years | - |
| Mngmt Effectiveness | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
ROE (5Y Avg) | -0.77 | |||
ROE last 12 Months | 3.03 | |||
ROA (5Y Avg) | -0.59 | |||
ROA last 12 Months | 2.11 | |||
ROC (5Y Avg) | 0.01 | |||
ROC last 12 Months | 2.86 | |||
Return on invested Capital Q | 0.60 | |||
Return on invested Capital Y | 0.70 | |||
Assets Turnover | 0.20 | |||
Receivables Turnover | 4.00 |
| Valuation | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| 61.70 | ||||
| 1.78 | ||||
| 5.09 | ||||
| 27.90 | ||||
| -161.80 | ||||
| 2.39 | ||||
| 16.37 | ||||
| 40.09 | ||||
| 35.93B | ||||
| Forward PE | - | |||
| PEG | - |
| Financial Strength | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| 1.20 | ||||
| 2.20 | ||||
| 0.18 | ||||
| 0.22 | ||||
| 6.20 | ||||
| Leverage Ratio | 1.40 |
| Profitability | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| 54.70 | ||||
| 8.70 | ||||
| 21.40 | ||||
| -3.20 | ||||
| 6.60 |
| Revenue | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| 7.02B | ||||
| 14.04 | ||||
| 0.87 | ||||
| 2.08 |
| Dividends | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| 0.30 | ||||
| 0.22 | ||||
| - | ||||
| - | ||||
| Payout ratio | - |
| Earnings History | Estimate | Reported | Surprise % |
|---|---|---|---|
| Q02 2023 | 0.62 | 0.69 | 11.29 |
| Q01 2023 | 0.60 | 0.70 | 16.67 |
| Q04 2022 | 0.42 | 0.42 | 0.00 |
| Q03 2022 | 0.48 | 0.50 | 4.17 |
| Q02 2022 | 0.55 | 0.63 | 14.55 |
| Q01 2022 | 0.52 | 0.68 | 30.77 |
| Q04 2021 | 0.49 | 0.56 | 14.29 |
| Q03 2021 | 0.49 | 0.54 | 10.20 |
| Earnings Per End | Estimate | Revision % | Trend |
|---|---|---|---|
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| Next Report Date | - |
| Estimated EPS Next Report | 0.62 |
| Estimates Count | 6 |
| EPS Growth Next 5 Years % | - |
| Volume Overview | |
|---|---|
| Volume | 700.80K |
| Shares Outstanding | 499.70K |
| Shares Float | 489.63M |
| Trades Count | 10.12K |
| Dollar Volume | 54.98M |
| Avg. Volume | 633.93K |
| Avg. Weekly Volume | 674.69K |
| Avg. Monthly Volume | 600.63K |
| Avg. Quarterly Volume | 626.47K |
Alcon Inc. (NYSE: ALC) stock closed at 78.25 per share at the end of the most recent trading day (a -0.15% change compared to the prior day closing price) with a volume of 700.80K shares and market capitalization of 39.10B. Is a component of indices and it is traded on NYSE exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 23655 people. Alcon Inc. CEO is David J. Endicott.
The one-year performance of Alcon Inc. stock is 26.85%, while year-to-date (YTD) performance is 14.15%. ALC stock has a five-year performance of %. Its 52-week range is between 55.21 and 86.2, which gives ALC stock a 52-week price range ratio of 74.35%
Alcon Inc. currently has a PE ratio of 61.70, a price-to-book (PB) ratio of 1.78, a price-to-sale (PS) ratio of 5.09, a price to cashflow ratio of 27.90, a PEG ratio of -, a ROA of 2.11%, a ROC of 2.86% and a ROE of 3.03%. The company’s profit margin is 6.60%, its EBITDA margin is 21.40%, and its revenue ttm is $7.02 Billion , which makes it $14.04 revenue per share.
Of the last four earnings reports from Alcon Inc., there were 3 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.62 for the next earnings report. Alcon Inc.’s next earnings report date is -.
The consensus rating of Wall Street analysts for Alcon Inc. is Moderate Buy (1.69), with a target price of $78.64, which is +0.50% compared to the current price. The earnings rating for Alcon Inc. stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Alcon Inc. has a dividend yield of 0.30% with a dividend per share of $0.22 and a payout ratio of -%.
Alcon Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 11.34, ATR14 : 1.20, CCI20 : -188.00, Chaikin Money Flow : -0.42, MACD : -0.90, Money Flow Index : 50.84, ROC : -3.89, RSI : 30.97, STOCH (14,3) : 1.50, STOCH RSI : 0.00, UO : 23.98, Williams %R : -98.50), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Alcon Inc. in the last 12-months were:
Alcon Inc.
Alcon, headquartered in Fort Worth, Texas, is the global eyecare leader with a diverse portfolio in ophthalmology including contact lenses, eye drops, surgical equipment, and related surgical products. Novartis purchased Alcon from Nestle in 2010 and, following nine years as a Novartis subsidiary, the company was spun-off as a public company in April 2019. The company reports five distinct segments: implantables (16% of revenue), consumables (31%), equipment (9%), contact lenses (27%), and ocular health (17%). The company is geographically diversified, with 41% of revenue in the U.S. market, and the firm has a strong presence in the European Union and Japan.
CEO: David J. Endicott
Telephone: +41 589112000
Address: Chemin de Blandonnet 8, Geneva 1214, , CH
Number of employees: 23 655
